Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Colorectal Neoplasms × Drug Therapy × Clear all

Phase

Phase 2 20 Phase 3 13 Phase NA 9 Phase 1/2 6 Phase 1 5 Phase 2/3 2 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2 Lymphoma, Non-Hodgkin 2 Adenocarcinoma 2 Pain 1 Oropharyngeal Neoplasms 1 Neoplasms, Second Primary 1 NSCLC 1 Multiple Myeloma 1 Localized Advanced Rectal Adenocarcinoma 1 Liver Neoplasms 1 HER-2 Negative Breast Cancer 1 Gastrointestinal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Acute Kidney Injury 1

Interventions

Capecitabine 11 Fluorouracil 9 Oxaliplatin 7 Bevacizumab 7 Leucovorin 5 Irinotecan 4 HMPL-013 4 Folfox protocol 4 Cetuximab 4 ferric carboxymaltose 3 regorafenib 2 gadolinium ethoxybenzyl DTPA 2 gadobenic acid 2 Triamcinolone 2 Standard of Care 2 Radiofrequency Ablation 2 Pirinitramide 2 Morphine 2 Esomeprazole 2 Analgesia, Epidural 2 sodium phosphate 1 raltitrexed 1 polyethylene glycol 3350 1 iron isomaltoside 1000 1 gadoteridol 1 gadoterate meglumine 1 gadodiamide 1 gadobutrol 1 fish oil triglycerides 1 ferrous sulfate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00510627 2017-03-03

Prometheus

Boston Scientific Corporation

Phase 4 Withdrawn

Gastrointestinal

Liver Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡